0,946  0,003  Antioxidant
0,909  0,003  Free radical scavenger
0,773  0,020  Apoptosis agonist
0,743  0,004  Antimutagenic
0,683  0,007  Antineoplastic (melanoma)
0,677  0,002  SULT1A3 substrate
0,683  0,011  Chemoprotective
0,612  0,004  Antidote
0,604  0,012  UGT1A9 substrate
0,598  0,009  UGT1A6 substrate
0,582  0,005  Genotoxic
0,559  0,015  Cardioprotectant
0,552  0,014  NOS2 expression inhibitor
0,551  0,015  AR expression inhibitor
0,541  0,033  Antileukemic
0,525  0,020  Radioprotector
0,515  0,012  Antineoplastic (glioblastoma multiforme)
0,523  0,041  TNF expression inhibitor
0,489  0,020  Antineoplastic (glioma)
0,493  0,043  Antibacterial
0,450  0,002  Creatine kinase inhibitor
0,440  0,014  UGT1A1 substrate
0,436  0,010  Hepatoprotectant
0,446  0,028  NOS3 expression inhibitor
0,465  0,050  Transcription factor NF kappa B inhibitor
0,442  0,033  Hepatic disorders treatment
0,411  0,004  Histidine decarboxylase inhibitor
0,447  0,052  Histamine release inhibitor
0,429  0,043  Aldehyde oxidase inhibitor
0,401  0,021  Angiogenesis stimulant
0,393  0,021  UDP-glucuronosyltransferase substrate
0,378  0,014  Skin whitener
0,392  0,029  Hypoglycemic
0,384  0,022  Antiulcerative
0,431  0,071  Antineoplastic (breast cancer)
0,369  0,014  UGT1A3 substrate
0,362  0,011  UGT2B15 substrate
0,380  0,030  Superoxide dismutase inhibitor
0,377  0,033  Proliferative diseases treatment
0,387  0,047  Antineoplastic (ovarian cancer)
0,392  0,054  Prostate cancer treatment
0,362  0,026  Peroxidase inhibitor
0,340  0,006  Antihemorrhagic
0,372  0,040  Cytotoxic
0,345  0,019  Antihypotensive
0,410  0,085  Antidiabetic
0,410  0,085  Cyclophilin D inhibitor
0,361  0,040  Cytostatic
0,355  0,034  Chemopreventive
0,352  0,034  Amyloid beta aggregation inhibitor
0,371  0,053  Caspase 3 stimulant
0,333  0,018  Melanin inhibitor
0,319  0,005  Carbonic anhydrase III inhibitor
0,319  0,010  Sulfotransferase substrate
0,330  0,032  5 Hydroxytryptamine uptake stimulant
0,302  0,008  Carbonic anhydrase XV inhibitor
0,309  0,017  NOS3 expression enhancer
0,415  0,130  Antiinflammatory
0,348  0,063  ICAM1 expression inhibitor
0,315  0,043  Vascular (periferal) disease treatment
0,328  0,058  Lipoxygenase inhibitor
0,275  0,007  Estrogen antagonist
0,267  0,006  Estrogen receptor beta antagonist
0,311  0,059  Antihypercholesterolemic
0,343  0,095  CYP2C19 inhibitor
0,256  0,012  Expectorant
0,305  0,068  CTGF expression inhibitor
0,259  0,023  Topoisomerase II inhibitor
0,240  0,009  Carbonic anhydrase VI inhibitor
0,310  0,082  Antithrombotic
0,274  0,046  Antihypertriglyceridemic
0,272  0,046  Nitric oxide antagonist
0,246  0,021  M18 aspartyl aminopeptidase inhibitor
0,252  0,031  Nitric-oxide synthase stimulant
0,236  0,017  Cystathionine beta-synthase inhibitor
0,260  0,043  DNA methylase inhibitor
0,243  0,030  Amylase inhibitor
0,241  0,036  Thrombolytic
0,277  0,077  CYP2C19 substrate
0,214  0,014  Cyclooxygenase 3 inhibitor
0,250  0,054  Carcinogenic
0,276  0,080  FMO3 substrate
0,232  0,037  Antiviral (Herpes)
0,222  0,028  Monophenol monooxygenase inhibitor
0,344  0,150  Caspase 9 stimulant
0,206  0,012  Mucolytic
0,335  0,143  Alpha-glucosidase inhibitor
0,214  0,024  DNA polymerase I inhibitor
0,212  0,026  Cell wall synthesis inhibitor
0,283  0,098  Apoptosis antagonist
0,232  0,049  UGT2B7 substrate
0,254  0,071  Platelet antagonist
0,240  0,058  Peptidyltransferase inhibitor
0,200  0,026  Glutathione S-transferase substrate
0,257  0,084  UGT2B4 substrate
0,210  0,038  Lipid peroxidase inhibitor
0,178  0,009  Estrogen agonist
0,182  0,015  Arylamine N-Acetyltransferase substrate
0,246  0,079  Antipyretic
0,171  0,005  Estrogen receptor beta agonist
0,175  0,011  Toll-Like receptor 4 antagonist
0,180  0,016  Papain-like protease (SARS coronavirus) inhibitor
0,167  0,004  Kinesin antagonist
0,167  0,004  Kinesin-like protein 1 inhibitor
0,254  0,095  Antihypoxic
0,221  0,062  Antiviral (Influenza)
0,176  0,017  Carbonic anhydrase XIII inhibitor
0,239  0,081  Antidiabetic symptomatic
0,249  0,097  Immunostimulant
0,205  0,054  Diabetic nephropathy treatment
0,151  0,007  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,166  0,023  UGT2B1 substrate
0,244  0,104  CYP1A2 substrate
0,163  0,024  Antineoplastic (uterine cancer)
0,205  0,066  Mutagenic
0,221  0,083  Embryotoxic
0,159  0,023  Gastric antisecretory
0,198  0,069  CYP2B6 inhibitor
0,248  0,120  Antineoplastic (osteosarcoma)
0,242  0,115  Antifungal
0,237  0,110  Antineoplastic (colorectal cancer)
0,144  0,017  SULT1E1 substrate
0,138  0,014  Estrogen receptor alpha antagonist
0,147  0,024  Topoisomerase II alpha inhibitor
0,237  0,113  CYP2D6 substrate
0,128  0,006  Estrogen receptor alpha agonist
0,154  0,033  SULT1A1 substrate
0,225  0,107  Transcription factor STAT inhibitor
0,225  0,108  Antineoplastic (colon cancer)
0,224  0,108  Antiosteoporotic
0,217  0,108  Flavin-containing monooxygenase substrate
0,191  0,085  Neurotrophic factor enhancer
0,126  0,027  Thioredoxin inhibitor
0,114  0,015  Prostaglandin EP2 antagonist
0,183  0,086  VEGF expression inhibitor
0,137  0,041  Chelator
0,175  0,079  LDLR expression enhancer
0,226  0,131  Bone diseases treatment
0,164  0,070  Interleukin 6 antagonist
0,125  0,032  Alcohol dehydrogenase inhibitor
0,143  0,050  Alkylator
0,245  0,154  CYP2C9 substrate
0,145  0,054  Interleukin 4 antagonist
0,117  0,028  Antibiotic
0,108  0,020  Aromatase inhibitor
0,137  0,051  Gastritis treatment
0,108  0,023  Antiviral (Hepatitis A)
0,180  0,096  Insulin sensitizer
0,224  0,142  GST M1-1 substrate
0,195  0,114  Antineoplastic (renal cancer)
0,192  0,112  Antineoplastic (non-small cell lung cancer)
0,126  0,047  GABA C receptor antagonist
0,095  0,018  Postmenopausal disorders treatment
0,123  0,049  5-Lipoxygenase inhibitor
0,161  0,093  DNA methyltransferase I inhibitor
0,162  0,097  Antihelmintic
0,121  0,061  Constipation treatment
0,128  0,070  Antibacterial (Helicobacter pylori)
0,091  0,036  Glutamate decarboxylase inhibitor
0,145  0,090  UGT1A4 substrate
0,060  0,005  Cholesterol absorption inhibitor
0,098  0,048  Restless leg syndrome treatment
0,151  0,102  Sensitization
0,102  0,058  Xanthine oxidase inhibitor
0,139  0,097  Growth hormone agonist
0,128  0,085  Protein kinase stimulant
0,134  0,093  Adenylate cyclase stimulant
0,226  0,186  15-Lipoxygenase inhibitor
0,082  0,043  SULT1A2 substrate
0,093  0,055  Aminoacyl-tRNA synthetase inhibitor
0,170  0,133  VCAM1 expression inhibitor
0,161  0,125  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,058  0,023  Squalene epoxidase inhibitor
0,115  0,079  Antiviral (Influenza B)
0,164  0,129  Antineoplastic (cervical cancer)
0,063  0,029  Postcoital contraceptive
0,049  0,016  Arginase inhibitor
0,209  0,176  GST A substrate
0,136  0,103  Antihelmintic (Nematodes)
0,102  0,072  DOPA decarboxylase inhibitor
0,143  0,114  Platelet adhesion inhibitor
0,068  0,040  HIV-1 integrase (3'-Processing) inhibitor
0,061  0,034  Carbonic anhydrase VB inhibitor
0,154  0,128  Antiparasitic
0,129  0,104  UGT2B9 substrate
0,065  0,040  Transcription factor RelA inhibitor
0,097  0,073  Topoisomerase I inhibitor
0,070  0,046  Phenylalanine 4-hydroxylase inhibitor
0,097  0,074  Beta glucuronidase inhibitor
0,080  0,057  Antineoplastic antibiotic
0,042  0,019  Glucose-6-phosphate dehydrogenase inhibitor
0,126  0,104  Anticoagulant
0,066  0,044  Glucagon-like peptide 1 agonist
0,207  0,186  FMO1 substrate
0,145  0,125  P-glycoprotein inhibitor
0,050  0,031  Antibiotic Glycopeptide-like
0,093  0,075  Urease inhibitor
0,071  0,053  Lipase inhibitor
0,067  0,050  Carbonic anhydrase VA inhibitor
0,144  0,126  Antineoplastic (bone cancer)
0,074  0,057  NAD(P)H dehydrogenase (quinone) inhibitor
0,130  0,115  Antipruritic, non-allergic
0,034  0,020  Estrogen-related receptor beta antagonist
0,065  0,054  5 Hydroxytryptamine 1F antagonist
0,079  0,069  Ornithine decarboxylase inhibitor
0,038  0,030  Dopamine D5 agonist
0,160  0,153  Antineoplastic (liver cancer)
0,101  0,096  Growth stimulant
0,109  0,104  Antihelmintic (Trematoda)
0,065  0,060  SULT2A1 substrate
0,097  0,092  Cholesterol synthesis inhibitor
0,176  0,171  Transcription factor STAT3 inhibitor
0,052  0,048  HIV-1 integrase (Strand Transfer) inhibitor
0,033  0,030  Antibiotic Aminoglycoside-like
0,059  0,055  Carbonic anhydrase V inhibitor
0,162  0,159  Lipoprotein disorders treatment
0,027  0,024  1,3-Beta-glucan synthase inhibitor
0,038  0,037  Hypogonadism treatment
0,082  0,081  Protein kinase C zeta inhibitor
0,196  0,196  Interleukin 2 agonist
0,097  0,097  Microtubule formation inhibitor

